Flucloxacillin: Clinical Trials

3 trials of Flucloxacillin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Terminated 1

Follow Flucloxacillin: new trials by email Literature Review of Flucloxacillin trials Research Report on Flucloxacillin

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA
Dalbavancin, Vancomycin, Oxacillin - Methicillin-Resistant Staphylococcus Aureus, Bacterial Infections
Phase 3CompletedAbbVie1992017-03-302024-09-19
Combination Antibiotic Therapy for Methicillin Resistant Staphylococcus Aureus Infection
Beta-Lactam - Methicillin-Resistant Staphylococcus Aureus
Phase 3TerminatedMenzies School of Health Research3582015-08-262018-12-19
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
Trimethoprim-Sulfamethoxazole, Clindamycin, Linezolid - Staphylococcus Aureus Infection
Phase 3CompletedHeinrich-Heine University, Duesseldorf2152013-12-012020-05-27

Conditions studied

Bacterial Infections (1)  ·  Sepsis (1)  ·  Staphylococcal Infections (1)  ·  Staphylococcal Skin Infections (1)

Sponsors

AbbVie (1)  ·  Heinrich-Heine University, Duesseldorf (1)  ·  Menzies School of Health Research (1)

Countries

Spain (2)  ·  Argentina (1)  ·  Australia (1)  ·  Belarus (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Chile (1)  ·  Colombia (1)  ·  France (1)  ·  Georgia (1)  ·  Germany (1)  ·  Greece (1)  ·  Guatemala (1)  ·  Israel (1)  ·  Latvia (1)

Top investigators

Achim J Kaasch, MD (1)  ·  Joshua Davis, MBBS, FRACP (1)  ·  Steven Tong, MBBS, FRACP (1)

Results publications

PMID 26452342, PMID 27029920, PMID 32044943, PMID 32051007, PMID 38244557

NIH funding

2014 (1)